Common use of Other Retained Rights Clause in Contracts

Other Retained Rights. Except for the rights and licenses specified in Section 5.1, no license or other rights are granted to Bayer under any intellectual property of Dimension or ReGenX, whether by implication, estoppel, or otherwise, whether, in the case of ReGenX, any such intellectual property dominates or is dominated by the Licensed Technology. Notwithstanding anything to the contrary in this Agreement, Dimension may use and permit others to use the Licensed Technology for any research, development, commercial, or other purposes, outside of the Field. Dimension shall use reasonable efforts and impose conditions on any of its licensees to whom it grants rights outside the Field to prevent use (intentional or unintentional) of the Licensed Technology inside the Field. Without limiting the foregoing, and notwithstanding anything in this Agreement to the contrary, Bayer acknowledges and understands that ReGenX and its direct and indirect licensors retain the rights under the Sublicensed Technology set forth in Exhibit C (individually and collectively, the “Retained Rights”).

Other Retained Rights. Except for the rights and licenses specified in Section 5.1, no license or other rights are granted to Bayer under any intellectual property of Dimension or ReGenX, whether by implication, estoppel, or otherwise, whether, in the case of ReGenX, any such intellectual property dominates or is dominated by the Licensed Technology or Dimension POC Technology. Notwithstanding anything to the contrary in this Agreement, Dimension may use and permit others to use the Licensed Technology for any research, development, commercial, or other purposes, outside of the Field. Dimension shall use reasonable efforts and impose conditions on any of its licensees to whom it grants rights under the Licensed Technology outside the Field to prevent use (intentional or unintentional) of the Licensed Technology inside the Field. Without limiting the foregoing, and notwithstanding anything in this Agreement to the contrary, Bayer acknowledges and understands that ReGenX and its direct and indirect licensors retain the rights under the Sublicensed Technology set forth in Exhibit C (individually and collectively, the “Retained Rights”).